Movement Alert｜JD Health Falls 3.02% in Regular Trading, GLP-1 Online Sales Regulations Continue to Pressure Online Pharmacy Business

Market Focus05-28

On May 28, JD Health fell 3.02% in regular trading, trading at HK$38.66/share, with trading volume of HK$59.45 million. The stock extended its multi-day selloff amid tightening regulations on online prescription drug sales.

On May 25, China's National Medical Products Administration issued the Compliance Guidelines for Online Retail of Prescription Drugs, requiring real prescriptions, real-name sales, and prohibiting AI from replacing licensed pharmacists in prescription review. The guidelines also ban platforms from guiding consumers toward excessive or unreasonable drug use. The regulation specifically targets GLP-1 weight-loss drugs such as semaglutide and tirzepatide, which since May 15 require valid hospital paper prescriptions for purchase, restricting internet hospital-issued prescriptions.

JD Health has conducted share buybacks for seven consecutive trading days since May 15, repurchasing a total of 11.61 million shares worth HK$474 million. Despite the aggressive buyback program, the stock has declined approximately 18% during the same period, reflecting sustained investor concerns over the regulatory impact on its core online pharmacy business.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181271127?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 09:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181271127","market":"hk","top_or_hot":-1,"title":"Movement Alert｜JD Health Falls 3.02% in Regular Trading, GLP-1 Online Sales Regulations Continue to Pressure Online Pharmacy Business","media":"Market Focus","content":"<p><p>On May 28, JD Health fell 3.02% in regular trading, trading at HK$38.66/share, with trading volume of HK$59.45 million. The stock extended its multi-day selloff amid tightening regulations on online prescription drug sales.</p><p>On May 25, China's National Medical Products Administration issued the Compliance Guidelines for Online Retail of Prescription Drugs, requiring real prescriptions, real-name sales, and prohibiting AI from replacing licensed pharmacists in prescription review. The guidelines also ban platforms from guiding consumers toward excessive or unreasonable drug use. The regulation specifically targets GLP-1 weight-loss drugs such as semaglutide and tirzepatide, which since May 15 require valid hospital paper prescriptions for purchase, restricting internet hospital-issued prescriptions.</p><p>JD Health has conducted share buybacks for seven consecutive trading days since May 15, repurchasing a total of 11.61 million shares worth HK$474 million. Despite the aggressive buyback program, the stock has declined approximately 18% during the same period, reflecting sustained investor concerns over the regulatory impact on its core online pharmacy business.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JD Health Falls 3.02% in Regular Trading, GLP-1 Online Sales Regulations Continue to Pressure Online Pharmacy Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JD Health Falls 3.02% in Regular Trading, GLP-1 Online Sales Regulations Continue to Pressure Online Pharmacy Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-28 09:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 28, JD Health fell 3.02% in regular trading, trading at HK$38.66/share, with trading volume of HK$59.45 million. The stock extended its multi-day selloff amid tightening regulations on online prescription drug sales.</p><p>On May 25, China's National Medical Products Administration issued the Compliance Guidelines for Online Retail of Prescription Drugs, requiring real prescriptions, real-name sales, and prohibiting AI from replacing licensed pharmacists in prescription review. The guidelines also ban platforms from guiding consumers toward excessive or unreasonable drug use. The regulation specifically targets GLP-1 weight-loss drugs such as semaglutide and tirzepatide, which since May 15 require valid hospital paper prescriptions for purchase, restricting internet hospital-issued prescriptions.</p><p>JD Health has conducted share buybacks for seven consecutive trading days since May 15, repurchasing a total of 11.61 million shares worth HK$474 million. Despite the aggressive buyback program, the stock has declined approximately 18% during the same period, reflecting sustained investor concerns over the regulatory impact on its core online pharmacy business.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1181271127","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181271127","pubTimestamp":1779933548,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 28, JD Health fell 3.02% in regular trading, trading at HK$38.66/share, with trading volume of HK$59.45 million. The stock extended its multi-day selloff amid tightening regulations on online...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"动静快讯|京东健康常规交易跌3.02%GLP-1线上销售规定持续施压网上药店业务","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"On May 28, JD Health fell 3.02% in regular trading, trading at HK$38.66/share, with trading volume of HK$59.45 million. The stock extended its multi-day selloff amid tightening regulations on online prescription drug sales.On May 25, China's National Medical Products Administration issued the Compliance Guidelines for Online Retail of Prescription Drugs, requiring real prescriptions, real-name sales, and prohibiting AI from replacing licensed pharmacists in prescription review. The guidelines also ban platforms from guiding consumers toward excessive or unreasonable drug use. The regulation specifically targets GLP-1 weight-loss drugs such as semaglutide and tirzepatide, which since May 15 require valid hospital paper prescriptions for purchase, restricting internet hospital-issued prescriptions.JD Health has conducted share buybacks for seven consecutive trading days since May 15, repurchasing a total of 11.61 million shares worth HK$474 million. Despite the aggressive buyback program, the stock has declined approximately 18% during the same period, reflecting sustained investor concerns over the regulatory impact on its core online pharmacy business.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181271127","isCrawlerRequest":true}